Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-β in human umbilical vein endothelial cells

Journal of Cellular Physiology

Volumn 193, Issue 3, 2002, Pages 299-318

  Ota, Tatsuru ^a,b   Fujii, Makiko ^b   Sugizaki, Takashi ^a   Ishii, Masami ^c   Miyazawa, Keiji ^a   Aburatani, Hiroyuki ^c   Miyazono, Kohei ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR; ACTIVIN RECEPTOR LIKE KINASE 1; BETA5 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; CLAUDIN; CLAUDIN 5; CONNEXIN 37; ENDOGLIN; EPHRIN; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INTEGRIN; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA; OLIGONUCLEOTIDE; PLAKOGLOBIN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DNA MICROARRAY; DOWN REGULATION; ENDOTHELIUM CELL; GENE TARGETING; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYBRIDIZATION; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENDU OSLER WEBER DISEASE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UMBILICAL VEIN; UNINDEXED SEQUENCE; UPREGULATION; VIRUS RECOMBINANT;

ACTIVIN RECEPTORS, TYPE I; ACTIVIN RECEPTORS, TYPE II; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; HUMANS; MODELS, BIOLOGICAL; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; UMBILICAL VEINS; UP-REGULATION;

EID: 0036888627     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10170     Document Type: Article

References (63)

1. Afrakhte M, Moren A, Jossan S, Itoh S, Sampath K, Westermark B, Heldin C-H, Heldin N-E, ten Dijke P. 1998. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun 249:505-511.
2. Akiyoshi S, Ishii M, Nemoto N, Kawabata M, Aburatani H, Miyazono K. 2001. Targets of transcriptional regulation by transforming growth factor-β: Expression profile analysis using oligonucleotide arrays. Jpn J Cancer Res 92:257-268.
3. Bartoli M, Gu X, Tsai NT, Venema RC, Brooks SE, Marrero MB, Caldwell RB. 2000. Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J Biol Chem 275:33189-33192.
4. Billings PC, Whitbeck JC, Adams CS, Abrams WR, Cohen AJ, Engelsberg BN, Howard PS, Rosenbloom J. 2002. The TGFβ-inducible matrix protein βig-h3 interacts with fibronectin. J Biol Chem 277:28003-28009.
5. Blanchette F, Day R, Dong W, Laprise MH, Dubois CM. 1997. TGFβ-regulates gene expression of its own converting enzyme furin. J Clin Invest 99:1974-1983.
6. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
7. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395.
8. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. 2001. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575-583.
9. Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM, Zwijsen A. 1999. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 126:1631-1642.
10. Dale M, Nicklin MJ. 1999. Interleukin-1 receptor cluster: Gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics 57:177-179.
11. Darnell JE, Jr., Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
12. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121:1845-1854.
13. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949.
14. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
15. Frisen J, Holmberg J, Barbacid M. 1999. Ephrins and their Eph receptors: Multitalented directors of embryonic development. EMBO J 18:5159-5165.
16. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. 2002. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 21:1743-1753.
17. Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C. 2002. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-β receptors I and II. J Biol Chem 277:29197-29209.
18. Heldin C-H, Miyazono K, ten Dijke P. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
19. Herren B, Raines EW, Ross R. 1997. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J 11:173-180.
20. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A. 1999. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274:19838-19845.
21. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
22. Holzman LB, Marks RM, Dixit VM. 1990. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol Cell Biol 10:5830-5838.
23. Ishida W, Hamamoto T, Kusanagi K, Yagi K, Kawabata M, Takehara K, Sampath TK, Kato M, Miyazono K. 2000. Smad6 is a Smad1/5-induced Smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 275:6075-6079.
24. Jacobson BS. 2000. Hereditary hemorrhagic telangiectasia: A model for blood vessel growth and enlargement. Am J Pathol 156:737-742.
25. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA. 1996. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189-195.
26. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25:153-159.
27. Keeton MR, Curriden SA, van Zonneveld AJ, Loskutoff DJ. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J Biol Chem 266:23048-23052.
28. Knudsen KA, Wheelock MJ. 1992. Plakoglobin, or an 83-kD homologue distinct from β-catenin, interacts with E-cadherin and N-cadherin. J Cell Biol 118:671-679.
29. Korpelainen EI, Karkkainen M, Gunji Y, Vikkula M, Alitalo K. 1999. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18:1-8.
30. Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, Leveen P, Xu X, ten Dijke P, Mummery CL, Karlsson S. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J 20:1663-1673.
31. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP. 1999. Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537.
32. Lux A, Attisano L, Marchuk DA. 1999. Assignment of transforming growth factor β1 and β3 and a third new ligand to the type I receptor ALK-1. J Biol Chem 274:9984-9992.
33. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R. 1999. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401:670-677.
34. Mathur M, Goodwin L, Cowin P. 1994. Interactions of the cytoplasmic domain of the desmosomal cadherin Dsg1 with plakoglobin. J Biol Chem 269:14075-14080.
35. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J. 1994. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345-351.
36. McLean JW, Vestal DJ, Cheresh DA, Bodary SC. 1990. cDNA sequence of the human integrin β5 subunit. J Biol Chem 265:17126-17131.
37. Morita K, Sasaki H, Furuse M, Tsukita S. 1999. Endothelial claudin: Claudin-5/TMVCF constitutes right junction strands in endothelial cells. J Cell Biol 147:185-194.
38. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin N-E, Heldin C-H, ten Dijke P. 1997. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389:631-635.
39. Nakashima K, Takizawa T, Ochiai W, Yanagisawa M, Hisatsune T, Nakafuku M, Miyazono K, Kishimoto T, Kageyama R, Taga T. 2001. BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc Natl Acad Sci USA 98:5868-5873.
40. Nath D, Slocombe PM, Stephens PE, Warn A, Hutchinson GR, Yamada KM, Docherty AJ, Murphy G. 1999. Interaction of metargidin (ADAM-15) with αvβ3 and α5β1 integrins on different haemopoietic cells. J Cell Sci 112:579-587.
41. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22.
42. Norton JD, Deed RW, Craggs G, Sablitzky F. 1998. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 8:58-65.
43. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-β signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97:2626-2631.
44. Oshima M, Oshima H, Taketo MM. 1996. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 179:297-302.
45. Pepper MS. 1997. Transforming growth factor-β: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-43.
46. Reed KE, Westphale EM, Larson DM, Wang HZ, Veenstra RD, Beyer EC. 1993. Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein. J Clin Invest 91:997-1004.
47. Ruiz P, Brinkmann V, Ledermann B, Behrend M, Grund C, Thalhammer C, Vogel F, Birchmeier C, Gunthert U, Franke WW, Birchmeier W. 1996. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol 135:215-225.
48. Saharinen J, Hyytiainen M, Taipale J, Keski-Oja J. 1999. Latent transforming growth factor-β binding proteins (LTBPs) - Structural extracellular matrix proteins for targeting TGF-β action. Cytokine Growth Factor Rev 10:99-117.
49. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74.
50. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
51. Shaw SK, Cepek KL, Murphy EA, Russell GJ, Brenner MB, Parker CM. 1994. Molecular cloning of the human mucosal lymphocyte integrin αE subunit. Unusual structure and restricted RNA distribution. J Biol Chem 269:6016-6025.
52. Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman J, Gimbrone MA, Jr., Anderson DJ. 2001. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230:139-150.
53. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. 1992. cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol 11:511-522.
54. Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P, Edelhoff S, Disteche C, Neubauer M, Marquardt H, et al. 1994. βig-h3: A transforming growth factor-β-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 13:571-584.
55. Solway J, Seltzer J, Samaha FF, Kim S, Alger LE, Niu Q, Morrisey EE, Ip HS, Parmacek MS. 1995. Structure and expression of a smooth muscle cell-specific gene, SM22α. J Biol Chem 270:13460-13469.
56. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
57. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591-594.
58. Tang XX, Pleasure DE, Ikegaki N. 1997. cDNA cloning, chromosomal localization, and expression pattern of EPLG8, a new member of the EPLG gene family encoding ligands of EPH-related protein-tyrosine kinase receptors. Genomics 41:17-24.
59. Tominaga S. 1989. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 258:301-304.
60. Urness LD, Sorensen LK, Li DY. 2000. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328-331.
61. Wang HU, Chen ZF, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins reve-aled by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753.
62. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
63. Yang X, Castilla LH, Xu X, Li C, Gotay J, Weinstein M, Liu PP, Deng CX. 1999. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126:1571-1580.